With increased survival of very premature infants in the United States and across the world, retinopathy of prematurity (ROP) remains a leading cause of preventable childhood visual impairment and blindness. Premature birth requires that retinal maturation take place in a physiologically abnormal environment, leading to retinal injury and dysregulated growth and development. Although the pathophysiology of ROP is understood to involve exposure to extrauterine hypoxia and hyperoxia, multiple international studies have failed to identify the optimal approach to preventing ROP. Clinical efforts therefore center on optimizing screening and identification of ROP and on improving ophthalmologic interventions to modify the course of vision-threatening disease.
Skip Nav Destination
Article navigation
February 2017
Article|
February 01 2017
Identification and Treatment of Retinopathy of Prematurity: Update 2017
Medha Sharma, MD;
Medha Sharma, MD
*Boston Children’s Hospital, Boston, MA
†Harvard Medical School, Boston, MA
Search for other works by this author on:
Deborah K. VanderVeen, MD
Deborah K. VanderVeen, MD
*Boston Children’s Hospital, Boston, MA
†Harvard Medical School, Boston, MA
Search for other works by this author on:
AUTHOR DISCLOSURE
Drs Sharma and VanderVeen have disclosed no financial relationships relevant to this article. This commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.
Neoreviews (2017) 18 (2): e84–e90.
Citation
Medha Sharma, Deborah K. VanderVeen; Identification and Treatment of Retinopathy of Prematurity: Update 2017. Neoreviews February 2017; 18 (2): e84–e90. https://doi.org/10.1542/neo.18-2-e84
Download citation file:
Sign in
Don't already have an account? Register
Purchased this content as a guest? Enter your email address to restore access.
Please enter valid email address.
Pay-Per-View Access
$35.00
Comments